One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus

Authors

James A. Simon, George Washington UniversityFollow
Vivian H. Lin, QuatRx Pharmaceuticals, Ann Arbor, MI
Cathy Radovich, QuatRx Pharmaceuticals, Ann Arbor, MI
Gloria A. Bachmann, University of Medicine and Dentistry of New Jersey
The Ospemifene Study Group

Document Type

Journal Article

Publication Date

4-2013

Journal

Menopause

Volume

Volume 20, Issue 4

Inclusive Pages

418-427

Keywords

Postmenopause; Selective Estrogen Receptor Modulators--therapeutic use; Tamoxifen--analogs & derivatives

APA Citation

Simon, J.A., Lin, V.H., Radovich, C., Bachmann, G.A., The Ospemifene Study Group. (2013). One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause, 20(4), 418-427.

Peer Reviewed

1